Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mayumi Nakagawa

Concepts (235)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
15
2024
173
4.490
Why?
Human papillomavirus 16
11
2021
44
3.550
Why?
Uterine Cervical Neoplasms
10
2024
299
3.270
Why?
Papillomavirus Vaccines
7
2021
70
3.220
Why?
Oncogene Proteins, Viral
11
2011
54
2.410
Why?
Papillomaviridae
7
2019
105
2.290
Why?
Repressor Proteins
9
2011
155
2.070
Why?
Epitopes, T-Lymphocyte
7
2018
26
1.870
Why?
Cancer Vaccines
3
2021
78
1.580
Why?
T-Lymphocytes
6
2021
340
1.400
Why?
Candida
4
2018
63
1.310
Why?
CD8-Positive T-Lymphocytes
6
2018
132
1.280
Why?
Cervix Uteri
3
2021
49
0.860
Why?
Uterine Cervical Dysplasia
2
2015
51
0.820
Why?
Immunity, Cellular
4
2013
64
0.720
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
78
0.710
Why?
Epitopes
2
2015
65
0.690
Why?
Langerhans Cells
3
2018
11
0.690
Why?
Neoplasms
2
2021
1325
0.650
Why?
Viral Load
2
2019
82
0.650
Why?
Health Education
1
2021
156
0.640
Why?
Cell Cycle Checkpoints
1
2019
32
0.630
Why?
HLA Antigens
4
2006
56
0.600
Why?
Humans
43
2025
52483
0.570
Why?
Adult
21
2025
14161
0.560
Why?
CD4-Positive T-Lymphocytes
3
2018
164
0.560
Why?
Colorectal Neoplasms
1
2021
294
0.560
Why?
Female
29
2025
28171
0.540
Why?
Health Knowledge, Attitudes, Practice
1
2021
509
0.520
Why?
Plasma Exchange
2
2014
25
0.500
Why?
Cross Protection
1
2015
4
0.480
Why?
T-Lymphocytes, Regulatory
2
2016
84
0.480
Why?
Colposcopy
1
2015
17
0.470
Why?
Interleukin-12
2
2018
27
0.470
Why?
Adjuvants, Immunologic
2
2018
52
0.460
Why?
Immunity, Innate
1
2015
117
0.440
Why?
Interferon-gamma
2
2012
180
0.430
Why?
Health
1
2013
21
0.430
Why?
Lectins, C-Type
1
2013
31
0.430
Why?
Papillomavirus E7 Proteins
8
2018
32
0.430
Why?
Middle Aged
15
2025
13028
0.420
Why?
Patient Selection
1
2015
259
0.420
Why?
Young Adult
9
2021
4329
0.410
Why?
Afibrinogenemia
1
2012
5
0.400
Why?
Enzyme-Linked Immunospot Assay
1
2012
3
0.390
Why?
T-Lymphocytes, Cytotoxic
4
2009
66
0.390
Why?
Breast Neoplasms
1
2021
1212
0.380
Why?
Cell Proliferation
5
2021
1023
0.360
Why?
Vaginal Smears
3
2021
28
0.360
Why?
Warts
1
2010
13
0.350
Why?
Plateletpheresis
1
2010
7
0.350
Why?
Antigens, Fungal
1
2010
20
0.350
Why?
Blood Preservation
1
2010
27
0.350
Why?
Early Detection of Cancer
3
2021
189
0.350
Why?
Dermatitis
1
2010
36
0.340
Why?
Blood Proteins
1
2010
85
0.340
Why?
Anaphylaxis
1
2010
69
0.330
Why?
Cells, Cultured
5
2021
1567
0.320
Why?
Antigens, Viral
2
2009
43
0.300
Why?
Immunotherapy
1
2010
244
0.300
Why?
Human papillomavirus 18
1
2008
9
0.300
Why?
Telemedicine
1
2015
494
0.300
Why?
Blood Platelets
1
2010
259
0.290
Why?
Host-Pathogen Interactions
2
2021
144
0.280
Why?
Vaccinia virus
1
2007
6
0.270
Why?
Dendritic Cells
1
2008
136
0.270
Why?
Hematopoietic Stem Cell Transplantation
2
2025
603
0.270
Why?
Immunoenzyme Techniques
1
2007
137
0.270
Why?
Immunophenotyping
1
2007
117
0.260
Why?
Neoplasm Staging
2
2025
772
0.260
Why?
Aged
10
2025
10121
0.240
Why?
Blood Component Removal
1
2025
15
0.240
Why?
Isoantibodies
1
2004
30
0.230
Why?
Cell Line, Tumor
5
2021
1470
0.230
Why?
Neoplasm Grading
2
2021
126
0.230
Why?
Lead
1
2004
33
0.230
Why?
Infant, Very Low Birth Weight
1
2004
48
0.220
Why?
Neutropenia
1
2004
115
0.220
Why?
Endometrial Neoplasms
1
2025
144
0.220
Why?
Oropharyngeal Neoplasms
1
2024
19
0.220
Why?
DNA, Viral
3
2011
137
0.220
Why?
Anus Neoplasms
1
2024
25
0.210
Why?
Hematopoietic Stem Cells
1
2025
187
0.210
Why?
Blood Transfusion
1
2004
127
0.210
Why?
Coinfection
1
2024
47
0.210
Why?
Penile Neoplasms
1
2024
44
0.210
Why?
High-Throughput Nucleotide Sequencing
2
2021
182
0.200
Why?
Adolescent
5
2021
6739
0.200
Why?
Antibody Formation
1
2002
51
0.200
Why?
Capsid Proteins
1
2002
24
0.200
Why?
Practice Guidelines as Topic
1
2025
488
0.190
Why?
Genes, T-Cell Receptor
1
2021
5
0.190
Why?
Clone Cells
3
2007
77
0.190
Why?
Clinical Trials, Phase I as Topic
1
2021
25
0.190
Why?
Treatment Outcome
3
2021
5422
0.190
Why?
Cytokines
2
2016
623
0.190
Why?
Pilot Projects
2
2021
721
0.180
Why?
Remission Induction
1
2021
218
0.180
Why?
Mass Screening
2
2021
357
0.180
Why?
Lymphocyte Activation
1
2021
172
0.180
Why?
Cystadenocarcinoma, Serous
1
2021
73
0.180
Why?
Videotape Recording
1
2021
27
0.180
Why?
Left-Right Determination Factors
1
2020
1
0.180
Why?
Nodal Protein
1
2020
3
0.180
Why?
Amino Acid Sequence
3
2008
578
0.170
Why?
Mammography
1
2021
99
0.170
Why?
Focus Groups
1
2021
196
0.170
Why?
Enzyme-Linked Immunosorbent Assay
3
2010
235
0.160
Why?
Multiple Myeloma
2
2025
3049
0.160
Why?
Metagenome
1
2019
40
0.160
Why?
Male
10
2024
26761
0.160
Why?
Glioblastoma
1
2020
97
0.160
Why?
Dose-Response Relationship, Drug
2
2016
1378
0.160
Why?
Parenteral Nutrition
1
2019
27
0.150
Why?
Feasibility Studies
1
2021
406
0.150
Why?
Up-Regulation
1
2020
454
0.150
Why?
Health Behavior
1
2021
257
0.150
Why?
Transplantation Conditioning
1
2019
93
0.150
Why?
DNA
1
2021
549
0.150
Why?
Time Factors
2
2021
2968
0.140
Why?
Leukocytes, Mononuclear
2
2016
123
0.140
Why?
Bacteria
1
2019
228
0.140
Why?
HLA-B Antigens
2
2008
8
0.140
Why?
Cell Line
2
2012
1030
0.140
Why?
Age Factors
1
2021
1132
0.140
Why?
Ovarian Neoplasms
1
2021
459
0.130
Why?
Brain Neoplasms
1
2020
291
0.130
Why?
Histocompatibility Antigens Class II
2
2008
36
0.130
Why?
Retrospective Studies
5
2025
6607
0.130
Why?
Vaccines, Subunit
1
2016
15
0.130
Why?
Head and Neck Neoplasms
1
2019
288
0.130
Why?
Body Mass Index
1
2019
689
0.120
Why?
Molecular Sequence Data
2
2008
778
0.120
Why?
Adaptive Immunity
1
2015
34
0.120
Why?
Chromatography, Liquid
1
2016
240
0.120
Why?
Leukocyte Count
2
2004
73
0.120
Why?
Peptides
2
2006
223
0.110
Why?
Factor VIII
1
2014
23
0.110
Why?
Tandem Mass Spectrometry
1
2016
251
0.110
Why?
Purpura, Thrombotic Thrombocytopenic
1
2014
14
0.110
Why?
ADAM Proteins
1
2014
20
0.110
Why?
Proteome
1
2016
171
0.110
Why?
Antigens, CD1
1
2013
9
0.110
Why?
Mannose-Binding Lectins
1
2013
8
0.110
Why?
Receptors, Pattern Recognition
1
2013
4
0.110
Why?
Indicators and Reagents
1
2013
36
0.110
Why?
Intracellular Space
1
2013
26
0.110
Why?
Skin Tests
1
2013
58
0.110
Why?
Vaccination
1
2016
298
0.110
Why?
Cadherins
1
2013
62
0.110
Why?
Proteomics
1
2016
329
0.100
Why?
Communication
1
2015
257
0.100
Why?
Rural Health Services
1
2015
170
0.100
Why?
Research Design
1
2015
359
0.100
Why?
Antigens, CD
1
2013
218
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
582
0.100
Why?
Socioeconomic Factors
1
2015
610
0.100
Why?
Longitudinal Studies
2
2005
747
0.090
Why?
Injections, Intralesional
1
2010
31
0.090
Why?
Isotonic Solutions
1
2010
20
0.090
Why?
Platelet Transfusion
1
2010
33
0.090
Why?
P-Selectin
1
2010
30
0.090
Why?
Sodium Chloride
1
2010
56
0.090
Why?
Platelet Aggregation
1
2010
72
0.090
Why?
Platelet Activation
1
2010
47
0.080
Why?
Hypersensitivity
1
2010
81
0.080
Why?
Japan
2
2025
38
0.080
Why?
Complement Factor I
1
2008
2
0.080
Why?
Polymerase Chain Reaction
1
2010
461
0.080
Why?
HLA-A Antigens
1
2008
11
0.070
Why?
Haplotypes
1
2008
92
0.070
Why?
Antigen Presentation
1
2008
26
0.070
Why?
Immunologic Memory
1
2008
31
0.070
Why?
Histocompatibility Antigens Class I
1
2008
48
0.070
Why?
Prognosis
2
2025
2099
0.070
Why?
Signal Transduction
2
2020
1671
0.070
Why?
DNA, Recombinant
1
2007
15
0.070
Why?
Genes, MHC Class I
1
2006
11
0.070
Why?
Animals
2
2019
13505
0.070
Why?
Binding, Competitive
1
2006
90
0.070
Why?
Arkansas
1
2013
2028
0.070
Why?
Polymorphism, Single Nucleotide
1
2008
505
0.060
Why?
Leukapheresis
1
2025
19
0.060
Why?
Antigens, CD34
1
2025
72
0.060
Why?
Calgranulin B
1
2005
4
0.060
Why?
Calgranulin A
1
2005
5
0.060
Why?
Cryopreservation
1
2025
41
0.060
Why?
Immunomagnetic Separation
1
2004
7
0.060
Why?
Epitope Mapping
1
2004
7
0.060
Why?
Societies, Medical
1
2025
200
0.060
Why?
Risk Factors
1
2013
3889
0.050
Why?
Transplantation, Autologous
1
2025
488
0.050
Why?
Phosphorylation
2
2020
528
0.050
Why?
Sensitivity and Specificity
1
2005
891
0.050
Why?
Mutation
1
2008
1347
0.050
Why?
Tumor Virus Infections
1
2002
48
0.050
Why?
Antibodies, Viral
1
2002
109
0.050
Why?
Lactobacillus
1
2021
4
0.050
Why?
SOX Transcription Factors
1
2021
4
0.050
Why?
Immunoglobulin G
1
2002
195
0.050
Why?
Neuroendocrine Cells
1
2021
10
0.050
Why?
Biological Specimen Banks
1
2021
22
0.050
Why?
Cytodiagnosis
1
2021
43
0.050
Why?
Neoplasm Recurrence, Local
1
2025
649
0.040
Why?
Cytoplasm
1
2021
94
0.040
Why?
Cobalt
1
2020
17
0.040
Why?
Recurrence
1
2002
672
0.040
Why?
Cell Hypoxia
1
2020
83
0.040
Why?
Vulnerable Populations
1
2020
52
0.040
Why?
Neoplastic Stem Cells
1
2021
99
0.040
Why?
Cohort Studies
1
2004
1542
0.040
Why?
Epithelial-Mesenchymal Transition
1
2020
57
0.040
Why?
Cell Movement
1
2021
268
0.040
Why?
Community Health Workers
1
2020
50
0.040
Why?
Multivariate Analysis
1
2021
591
0.040
Why?
Parenteral Nutrition, Total
1
2019
29
0.040
Why?
Sequence Analysis, DNA
1
2019
229
0.040
Why?
Cell Survival
1
2020
612
0.040
Why?
Cell Differentiation
1
2021
665
0.040
Why?
Phenotype
1
2021
789
0.040
Why?
Linear Models
1
2019
287
0.040
Why?
Models, Biological
1
2021
735
0.040
Why?
Immunity, Humoral
1
2018
23
0.040
Why?
Aged, 80 and over
1
2025
3392
0.040
Why?
Infant, Newborn
1
2004
2867
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2020
857
0.030
Why?
Autoantibodies
1
2014
121
0.030
Why?
Immunosuppressive Agents
1
2014
243
0.020
Why?
Mice, Inbred C57BL
1
2018
1884
0.020
Why?
Combined Modality Therapy
1
2014
639
0.020
Why?
Genetics, Population
1
2008
13
0.020
Why?
Alleles
1
2008
276
0.020
Why?
Mice
1
2018
5949
0.020
Why?
Casein Kinase II
1
2005
10
0.010
Why?
Cell Division
1
2005
291
0.010
Why?
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description